TEXT-EXTRACT 2 filename2.txt April 9, 2019 Justin Hall Interim Chief Executive Officer NovaBay Pharmaceuticals, Inc. 2000 Powell Street, Suite 1150 Emeryville, CA 94608 Re: NovaBay Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed April 1, 2019 File No. 333-230672 Dear Mr. Hall: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tonya K. Aldave at (202) 551-3601 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Abby E. Brown, Esq.